Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Roberto Chicharro Martin
Introduction
Roberto Chicharro Martin is a notable inventor based in Juan de la Cierva, Spain. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on isoquinoline derivatives. His research focuses on developing compounds that can serve as effective calpain inhibitors, which are crucial in the treatment of degenerative diseases.
Latest Patents
Roberto Chicharro Martin holds a patent for "Isoquinoline derivatives as calpain inhibitors." This invention relates to derivative compounds of partially-reduced isoquinoline, specifically those with a sec-butyl group substitution at position 3. The inventive compound includes an ester or amide derived from (3-sec-butyl-1-oxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid and (3-sec-butyl-1-thioxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid. These compounds can be utilized in the preventive or therapeutic treatment of degenerative diseases, showcasing their potential in medical applications.
Career Highlights
Roberto Chicharro Martin is affiliated with the Consejo Superior de Investigaciones Científicas, where he conducts his research. His work has led to the development of innovative compounds that have the potential to impact the field of medicine significantly. With a focus on calpain inhibitors, he has contributed to advancing therapeutic options for various degenerative conditions.
Collaborations
Roberto has collaborated with esteemed colleagues such as Bernardo Herradon García and Vicente Jesús Aran Redo. These collaborations have enriched his research and contributed to the advancement of knowledge in the field of medicinal chemistry.
Conclusion
Roberto Chicharro Martin's innovative work on isoquinoline derivatives exemplifies the importance of research in developing new therapeutic options. His contributions to the field of medicinal chemistry are noteworthy and have the potential to make a significant impact on the treatment of degenerative diseases.